Observational Study Protocol: LIVER-R

Trial Identifier: D419CR00035
Sponsor: AstraZeneca
Collaborator:
ICON Plc
NCTID:: NCT06252753
Start Date: December 2023
Primary Completion Date: December 2029
Study Completion Date: December 2029

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France, Alsace Strasbourg, Alsace, France, 67000
France, Auvergne-Rhône-Alpes Grenoble, Auvergne-Rhône-Alpes, France, 38700
France, Bretagne St Malo, Bretagne, France, 35403
France, Grand Est Mulhouse, Grand Est, France, 68100
France, Provence-Alpes-Cote d'Azur Avignon, Provence-Alpes-Cote d'Azur, France, 84918
France, Provence-Alpes-Cote d'Azur Marseille, Provence-Alpes-Cote d'Azur, France, 13008
Germany, Bavaria Augsburg, Bavaria, Germany, 86150
Germany, Lower Saxony Hannover, Lower Saxony, Germany, 30161
Germany, North Rhine-Westphalia Dortmund, North Rhine-Westphalia, Germany, 44137
Germany, North Rhine-Westphalia Stolberg, North Rhine-Westphalia, Germany, 52222
Germany, Saxony Dresden, Saxony, Germany, 01307
Germany, Saxony-Anhalt Halle (Saale), Saxony-Anhalt, Germany, 6108
Greece, Central Macedonia Thessaloniki, Central Macedonia, Greece, 55236
Greece, Thessaly Larissa, Thessaly, Greece, 41110
Italy, Campania Naples, Campania, Italy, 80131
Italy, Lombardy Brescia, Lombardy, Italy, 25123
Puerto Rico, Northern Plains San Juan, Northern Plains, Puerto Rico, 00935
United States of America, CA Coronado, CA, United States of America, 92118
United States of America, FL Gainesville, FL, United States of America, 32610
United States of America, IL Hinsdale, IL, United States of America, 60521
United States of America, OH Canton, OH, United States of America, 44718
United States of America, TX Temple, TX, United States of America, 76508